GlassScriptPhysician profile
Casmir A Ezim
NPI 1841710381
$21,000.56
in general payments reported to CMS, 2019-2025
39 companies · $3,375 in 2025
The $3,375 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $207 · 2021: $2,842 · 2022: $2,125 · 2023: $7,728 · 2024: $3,761 · 2025: $3,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,901 · Food and Beverage: $4,107 · Travel and Lodging: $2,840 · Education: $16.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,900.50 |
| Food and Beverage | $4,107.42 |
| Travel and Lodging | $2,839.85 |
| Education | $16.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $11,367.63 | 2019-2025 | Puraply Antimicrobial, Novachor, Affinity |
| Smith+Nephew, INC. | $4,173.40 | 2020-2025 | Oasis, Acticoat 4" X 4", Pico |
| Smoky Mountain Surgical LLC | $1,439.10 | 2023-2025 | |
| Medical Device Business Services, INC. | $639.24 | 2021 | |
| Stryker Corporation | $530.31 | 2019-2025 | 7 X 23mm Citrelock Implant, Augment Injectable, Bioskin |
| Arthrex, INC. | $442.48 | 2023 | |
| Abbvie INC. | $367.59 | 2021-2025 | |
| Linvatec Corporation | $363.16 | 2019 | |
| Integra Lifesciences Corporation | $254.89 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $138.80 | 2021-2023 | Senza |
| Acera Surgical, INC. | $120.53 | 2020-2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $115.90 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $104.82 | 2019 | |
| Tactile Systems Technology INC | $68.11 | 2020-2022 | |
| Medtronic, INC. | $66.06 | 2023-2024 | Intellis Adaptivestim |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $62.67 | 2023 | Seglentis |
| Bioventus LLC | $60.21 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.75 | 2025 | Jublia |
| Baxter Healthcare | $49.29 | 2025 | Floseal, Perclot |
| Grt US Holding, INC. | $48.22 | 2021-2022 | |
| Sanara Medtech INC. | $46.76 | 2023-2024 | Celleraterx |
| Kerecis Limited | $46.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Solventum Corporation | $45.30 | 2024-2025 | Activ.A.C. |
| Alpha Orthopedic Systems | $41.34 | 2022 | |
| Angiodynamics, INC. | $39.17 | 2021 | |
| Paratek Pharmaceuticals, INC. | $35.89 | 2022-2024 | Nuzyra |
| Royal Biologics, INC. | $34.52 | 2024 | |
| Mimedx Group, INC. | $34.33 | 2025 | |
| Abbott Laboratories | $34.07 | 2023 | Proclaim, Eterna |
| Depuy Synthes Sales INC. | $28.36 | 2023 | Hammerlock |
| Melinta Therapeutics, LLC | $25.22 | 2023 | Kimyrsa |
| Wright Medical Technology, INC. | $24.10 | 2019 | |
| Convatec INC. | $17.83 | 2023 | |
| Acell, INC. | $17.44 | 2020 | |
| Kci USA, INC. | $17.07 | 2021 | |
| Amgen INC. | $15.55 | 2024 | Krystexxa |
| Cashflow Solutions, LLC | $13.16 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Advanced Oxygen Therapy INC. | $11.42 | 2025 | Topical Oxygen Chamber For Extremities |
| Orthofix Medical, INC. | $10.24 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casmir Ezim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.